Annual Total Expenses
$62.29 M
+$1.41 M+2.32%
31 December 2023
Summary:
Cytosorbents annual total expenses is currently $62.29 million, with the most recent change of +$1.41 million (+2.32%) on 31 December 2023. During the last 3 years, it has risen by +$12.47 million (+25.03%). CTSO annual total expenses is now -0.89% below its all-time high of $62.85 million, reached on 31 December 2021.CTSO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$13.01 M
+$748.40 K+6.10%
30 September 2024
Summary:
Cytosorbents quarterly total expenses is currently $13.01 million, with the most recent change of +$748.40 thousand (+6.10%) on 30 September 2024. Over the past year, it has dropped by -$2.10 million (-13.87%). CTSO quarterly total expenses is now -32.45% below its all-time high of $19.26 million, reached on 31 December 2021.CTSO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.3% | -13.9% |
| 3 y3 years | +25.0% | -9.1% |
| 5 y5 years | +73.8% | +14.6% |
CTSO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.9% | +25.0% | -32.5% | +6.1% |
| 5 y | 5 years | -0.9% | +73.8% | -32.5% | +22.3% |
| alltime | all time | -0.9% | +2105.9% | -32.5% | +1703.5% |
Cytosorbents Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.01 M(+6.1%) |
| June 2024 | - | $12.26 M(-11.9%) |
| Mar 2024 | - | $13.91 M(-16.6%) |
| Dec 2023 | $62.29 M(+2.3%) | $16.69 M(+10.5%) |
| Sept 2023 | - | $15.10 M(+3.2%) |
| June 2023 | - | $14.63 M(-7.4%) |
| Mar 2023 | - | $15.80 M(+12.9%) |
| Dec 2022 | $60.88 M(-3.1%) | $14.00 M(-9.6%) |
| Sept 2022 | - | $15.48 M(-1.3%) |
| June 2022 | - | $15.69 M(-0.2%) |
| Mar 2022 | - | $15.72 M(-18.4%) |
| Dec 2021 | $62.85 M(+26.2%) | $19.26 M(+34.6%) |
| Sept 2021 | - | $14.31 M(-12.2%) |
| June 2021 | - | $16.29 M(+25.4%) |
| Mar 2021 | - | $13.00 M(-8.3%) |
| Dec 2020 | $49.82 M(+19.4%) | $14.16 M(+16.1%) |
| Sept 2020 | - | $12.21 M(-4.8%) |
| June 2020 | - | $12.82 M(+20.5%) |
| Mar 2020 | - | $10.63 M(-11.7%) |
| Dec 2019 | $41.74 M(+16.5%) | $12.04 M(+6.0%) |
| Sept 2019 | - | $11.36 M(+19.8%) |
| June 2019 | - | $9.48 M(+7.0%) |
| Mar 2019 | - | $8.86 M(-19.8%) |
| Dec 2018 | $35.84 M(+54.3%) | $11.06 M(+41.5%) |
| Sept 2018 | - | $7.81 M(-17.2%) |
| June 2018 | - | $9.43 M(+25.2%) |
| Mar 2018 | - | $7.53 M(-7.0%) |
| Dec 2017 | $23.22 M(+17.9%) | $8.10 M(+44.7%) |
| Sept 2017 | - | $5.60 M(+4.2%) |
| June 2017 | - | $5.37 M(+29.3%) |
| Mar 2017 | - | $4.15 M(-42.2%) |
| Dec 2016 | $19.70 M(+47.4%) | $7.18 M(+67.5%) |
| Sept 2016 | - | $4.29 M(-5.6%) |
| June 2016 | - | $4.54 M(+23.1%) |
| Mar 2016 | - | $3.69 M(-11.3%) |
| Dec 2015 | $13.36 M | $4.16 M(+29.1%) |
| Sept 2015 | - | $3.22 M(+7.0%) |
| June 2015 | - | $3.01 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $2.97 M(-21.4%) |
| Dec 2014 | $10.04 M(+81.3%) | $3.78 M(+50.0%) |
| Sept 2014 | - | $2.52 M(+24.1%) |
| June 2014 | - | $2.03 M(+17.6%) |
| Mar 2014 | - | $1.73 M(+30.8%) |
| Dec 2013 | $5.54 M(+52.0%) | $1.32 M(+21.7%) |
| Sept 2013 | - | $1.08 M(-29.4%) |
| June 2013 | - | $1.53 M(-4.0%) |
| Mar 2013 | - | $1.60 M(+77.4%) |
| Dec 2012 | $3.64 M(-18.6%) | $900.90 K(+46.5%) |
| Sept 2012 | - | $614.90 K(-41.0%) |
| June 2012 | - | $1.04 M(-3.8%) |
| Mar 2012 | - | $1.08 M(+7.9%) |
| Dec 2011 | $4.47 M(+58.4%) | $1.00 M(-18.0%) |
| Sept 2011 | - | $1.23 M(+10.0%) |
| June 2011 | - | $1.11 M(-1.3%) |
| Mar 2011 | - | $1.13 M(+181.3%) |
| Dec 2010 | $2.82 M(-6.7%) | $401.20 K(-48.6%) |
| Sept 2010 | - | $780.70 K(+15.8%) |
| June 2010 | - | $674.40 K(-30.3%) |
| Mar 2010 | - | $967.80 K(+70.4%) |
| Dec 2009 | $3.03 M(-6.7%) | $567.90 K(-32.4%) |
| Sept 2009 | - | $840.60 K(-1.5%) |
| June 2009 | - | $853.30 K(+11.5%) |
| Mar 2009 | - | $765.60 K(-16.4%) |
| Dec 2008 | $3.24 M(+5.8%) | $916.00 K(+5.3%) |
| Sept 2008 | - | $870.30 K(-207.3%) |
| June 2008 | - | -$811.30 K(-225.5%) |
| Mar 2008 | - | $646.60 K(+7.2%) |
| Dec 2007 | $3.07 M(+3.5%) | $603.20 K(-12.1%) |
| Sept 2007 | - | $686.20 K(+11.1%) |
| June 2007 | - | $617.90 K(-46.7%) |
| Mar 2007 | - | $1.16 M(+28.4%) |
| Dec 2006 | $2.96 M | $903.00 K(+35.1%) |
| Sept 2006 | - | $668.50 K(+15.0%) |
| June 2006 | - | $581.40 K(+4052.9%) |
| Feb 2006 | - | $14.00 K(+6.9%) |
| Nov 2005 | - | $13.10 K(-98.4%) |
| Aug 2005 | - | $811.30 K |
FAQ
- What is Cytosorbents annual total expenses?
- What is the all time high annual total expenses for Cytosorbents?
- What is Cytosorbents annual total expenses year-on-year change?
- What is Cytosorbents quarterly total expenses?
- What is the all time high quarterly total expenses for Cytosorbents?
- What is Cytosorbents quarterly total expenses year-on-year change?
What is Cytosorbents annual total expenses?
The current annual total expenses of CTSO is $62.29 M
What is the all time high annual total expenses for Cytosorbents?
Cytosorbents all-time high annual total expenses is $62.85 M
What is Cytosorbents annual total expenses year-on-year change?
Over the past year, CTSO annual total expenses has changed by +$1.41 M (+2.32%)
What is Cytosorbents quarterly total expenses?
The current quarterly total expenses of CTSO is $13.01 M
What is the all time high quarterly total expenses for Cytosorbents?
Cytosorbents all-time high quarterly total expenses is $19.26 M
What is Cytosorbents quarterly total expenses year-on-year change?
Over the past year, CTSO quarterly total expenses has changed by -$2.10 M (-13.87%)